Thérapie ciblée

← Retour à tous les articles

Targeted therapy

Disclaimer: The following information is for educational purposes only and is not intended as medical advice. Always consult with a healthcare professional for medical advice and treatment.

Targeted therapies for lung cancer are a form of treatment specifically aimed at the molecular changes in cancer cells. Through DNA and/or RNA analysis of cancer cells, also known as molecular research, the doctor can determine if specific mutations are present in the cancer cells.

Mutations are alterations in DNA that may lead to uncontrolled growth and division of the cancer cells. Targeted therapies can inhibit these processes. The type of targeted therapy depends on the results of DNA and/or RNA analysis, your medical history, and the current available scientific knowledge.

Certain targeted medications are administered intravenously or subcutaneously, while others are given in pill form. They can be administered alone (often in stage IV), or combined with other treatments such as surgery, chemotherapy, or radiotherapy, or other targeted therapies.
Some people may experience significant side effects, while others may experience fewer issues. Everyone responds differently to a particular treatment, and each therapy is unique. Some examples include:
  • Diarrhea
  • Reduced appetite
  • Acne-like skin rash
  • Fatigue
Your healthcare team works closely with you to manage and alleviate these side effects.

For more information, you can visit: cancer.gov/types/lung

Lire notre processus de révision éditoriale et médicale